Alvotech (ALVO) Share-based Compensation (IS) (2022)

Alvotech (ALVO) reported Share-based Compensation (IS) of $4.6 million for Q4 2022.

Alvotech (ALVO) Share-based Compensation (IS) (2022) Analysis & Trends

Alvotech has reported Share-based Compensation (IS) for 1 years, with the latest figure at $4.6 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (IS) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Alvotech 12.16 Mn -160.20 Mn -22.39 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 4.63 Mn
Dec 31, 2022 4.63 Mn